Metabolic compromise with systemic 3-nitropropionic acid produces striatal apoptosis in Sprague-Dawley rats but not in BALB/c ByJ mice

Experimental Neurology

Volumn 153, Issue 1, 1998, Pages 74-93

  Alexi, Tajrena ^a,d   Hughes, Paul E ^c,d   Knüsel, Beat ^c   Tobin, Allan J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

DNA fragmentation; Energy compromise; Glial reactivity; Huntington's disease; Metabolic inhibition; Mitochondrial respiration; Species differences; Succinate dehydrogenase; TUNEL

Indexed keywords

3 NITROPROPIONIC ACID; SUCCINATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL LABELING; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; MITOCHONDRIAL RESPIRATION; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031691460     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6842     Document Type: Article

References (69)

1. Albin, R. L., and J. T. Greenamyre. 1992. Alternative excitotoxic hypotheses. Neurology 42: 733-738.
2. Alexi, T., P. E. Hughes, R. L. M. Faull, and C. E. Williams. 1998. 3-Nitropropionic acid's lethal triplet: Cooperative pathways of neurodegeneration. NeuroReport, in press.
3. Beal, M. F. 1995. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38: 357-366.
4. Beal, M. F., E. Brouillet, B. G. Jenkins, R. J. Ferrante, N. W. Kowall, J. M. Miller, E. Storey, R. Srivastava, B. R. Rosen, and B. T. Hyman. 1993. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci. 13: 4181-4192.
5. Beal, M. F., R. J. Ferrante, R. Henshaw, R. T. Matthews, P. K. Chan, N. W. Kowall, C. J. Epstein, and J. B. Schulz. 1995. 3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc Superoxide dismutase transgenic mice. J. Neurochem. 65: 919-922.
6. Behrens, M. I., J. Koh, L. M. T. Canzoniero, S. L. Sensi, C. A. Csernansky, and D. W. Choi. 1995. 3-Nitropropionic acid induces apoptosis in cultured striatal and cortical neurons. NeuroReport 6: 545-548.
7. Borlongan, C. V., T. K. Koutouzis, T. S. Randall, T. B. Freeman, D. W. Cahill, and P. R. Sanberg. 1995. Systemic 3-nitropropionic acid: Behavioral deficits and striatal damage in adult rats. Brain Res. Bull. 36: 549-556.
8. Borlongan, C. V., T. K. Koutouzis, and P. R. Sanberg. 1997. 3-Nitropropionic acid animal model and Huntington's Disease. Neurosci. Biobehav. Rev. 21: 289-293.
9. Borlongan, C. V., H. Nishino, and P. R. Sanberg. 1997. Systemic, but not intraparenchymal, administration of 3-nitropropionic acid mimics the neuropathology of Huntington's disease: A speculative explanation. Neurosci. Res. 28:185-189.
10. Bossi, S. R., J. R. Simpson, and O. Isacson. 1993. Age dependence of striatal neuronal death caused by mitochondrial dysfunction. NeuroReport 4: 73-76.
11. Brouillet, E., B. G. Jenkins, B. T. Hyman, R. J. Ferrante, N. W. Kowall, R. Srivastava, D. S. Roy, B. R. Rosen, and M. F. Beal. 1993. Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J. Neurochem. 60: 356-359.
12. Charriaut-Marlangue, C., and Y. Ben-Ari. 1995. A cautionary note on the use of the TUNEL stain to determine apoptosis. NeuroReport 7: 61-64.
13. Choi, D. W. 1997. Background genes: Out of sight, but not out of brain. Trends Neurosci. 20: 499-500.
14. Clarke, P. G. H. 1990. Developmental cell death: morphological diversity and multiple mechanisms. Anat. Embryol. 181: 195-215.
15. Cohen, G. 1986. Monoamine oxidase, hydrogen peroxide, and Parkinson's disease. Adv. Neurol. 45: 119-125.
16. Dawson, R., Jr., M. F. Beal, S. C. Bondy, D. A. DiMonte, and G. E. Isom. 1995. Excitotoxins, aging, and environmental neurotoxins: Implications for understanding human neurodegenerative diseases. Toxicol. Appl. Pharmacol. 134:1-17.
17. 2+ exchanger. Exp. Neurol. 145: 38-45.
18. Dragunow, M., R. L. M. Faull, P. Lawlor, E. J. Beilharz, K. Singleton, E. B. Walker, and E. Mee. 1995. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. NeuroReport 6:1053-1057.
19. Frim, D. M., J. Simpson, T. A. Uhler, M. P. Short, S. R. Bossi, X. O. Breakefield, and O. Isacson. 1993. Striatal degeneration induced by mitochondrial blockade is prevented by biologically delivered NGF. J. Neurosci. Res. 35: 452-458.
20. Fu, Y. T., F. S. He, S. L. Zhang, and J. S. Zhang. 1995. Lipid peroxidation in rats intoxicated with 3-nitropropionic acid. Toxicon 33: 327-331.
21. 2+ overload induced by a mitochondrial toxin, 3-nitropropionic acid. Neuroscience, in press.
22. Gavrieli, Y., Y. Sherman, and S. A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNAfragmentation. J. Cell Biol. 119: 493-501.
23. Gehrmann, J., and G. W. Kreutzberg. 1995. Microglia in experimental neuropathology. In Neuroglia (H. Kettenmann and B. R. Ransom, Eds.), pp. 883-904. Oxford Univ. Press, New York.
24. Giovanni, A., B. A. Sieber, R. E. Heikkila, and P. K. Sonsalla. 1994. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. 1. Systemic administration. J. Pharmacol. Exp. Ther. 270: 1000-1007.
25. Gould, D. H., and D. L. Gustine. 1982. Basal ganglia degeneration, myelin alterations, and enzyme inhibition induced in mice by the plant toxin 3-nitropropanoic acid. Neuropathol. Appl. Neurobiol. 8: 377-393.
26. Graeber, M. B., W. J. Streit, and G. W. Kreutzberg. 1988. Axotomy of the rat facial nerve leads to increased CR3 complement receptor expression by activated microglial cells. J. Neurosci. Res. 21: 18-24.
27. Greene, J. G., and J. T. Greenamyre. 1995. Exacerbation of NMDA, AMPA, and L-glutamate excitotoxicity by the succinate dehydrogenase inhibitor malonate. J. Neurochem. 64: 2332-2338.
28. Greene, J. G., and J. T. Greenamyre. 1996. Bioenergetics and excitotoxicity: The Weak Excitotoxic Hypothesis. In Neurodegeneration and Neuroprotection in Parkinson's Disease (C. W. Olanow, P. Jenner, and M. Youdim, Eds.), pp. 125-142. Academic Press, London.
29. Greene, J. G., R. H. P. Porter, R. V. Eller, and J. T. Greenamyre. 1993. Inhibition of succinate dehydrogenase by malonic acid produces an "excitotoxic" lesion in rat striatum. J. Neurochem. 61: 1151-1154.
30. Guyot, M.-C., P. Hantraye, R. Dolan, S. Palfi, M. Maziere, and E. Brouillet. 1997. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid. Neuroscience 79: 45-56.
31. Hamilton, B. F., and D. H. Gould. 1987. Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: A type of hypoxic (energy deficient) brain damage. Acta Neuropathol. (Berl.) 72: 286-297.
32. Hassel, B., and U. Sonnewald. 1995. Selective inhibition of the tricarboxylic acid cycle of GABAergic neurons with 3-nitropropionic acid in vivo. J. Neurochem. 65: 1184-1191.
33. He, F., Z. Shoulin, F. Qian, and C. Zhang. 1995. Delayed dystonia with striatal CT lucencies induced by a mycotoxin (3-nitropropionic acid). Neurology 45: 2178-2183.
34. Hughes, P. E., T. Alexi, T. Yoshida, S. S. Schreiber, and B. Knüsel. 1996. Excitotoxic lesion of rat brain with quinolinic acid induces expression of p53 messenger RNA and protein and p53-inducible genes Bax and Gadd-45 in brain areas showing DNA fragmentation. Neurosci. 74: 1143-1160.
35. Hunt, R. D. 1966. Microscopic histochemical methods for the demonstration of enzymes. In Selected Histochemical and Histopathological Methods (S. W. Thompson, Ed.), pp. 697-700. Charles C. Thomas, Springfield, IL.
36. Kasof, G. M., A. Mandelzys, S. D. Maika, R. E. Hammer, T. Curran, and J. I. Morgan. 1995. Kainic acid-induced neuronal death is associated with DNA damage and a unique immediate-early gene response in c-fos-lacZ transgenic rats. J. Neurosci. 15: 4238-4249.
37. Kerr, J. F. R., and B. V. Harmon. 1991. Definition and incidence of apoptosis: An historical perspective. In Apoptosis: The Molecular Basis of Cell Death (L. D. Tomei and F. O. Cope, Eds.), pp. 5-29. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
38. Kirino, T., and K. Sano. 1984. Fine structural nature of delayed neuronal death following ischemia in the gerbil hippocampus. Acta Neuropathol. 62: 209-218.
39. Kuroiwa, T., M. Terakado, T. Yamaguchi, S. Endo, M. Ueki, and R. Okeda. 1996. The pyramidal cell layer of sector CA1 shows the lowest hippocampal succinate dehydrogenase activity in normal and postischemic gerbils. Neurosci. Lett. 206: 117-120.
40. Langston, J. W., P. Ballard, J. W. Tetrud, and I. Irwin. 1983. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219: 979-980.
41. Langston, J. W., L. S. Forno, C. S. Robert, and I. Irwin. 1984. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the squirrel monkey. Brain Res. 292: 390-394.
42. Ludolph, A. C., F. He, P. S. Spencer, J. Hammerstad, and M. Sabri. 1991. 3-Nitropropionic acid - Exogenous animal neurotoxin and possible human striatal toxin. Can. J. Neurol. Sci. 18: 492-498.
43. McLaughlin, B. A., D. Nelson, M. Erecinska, and M.-F. Chesselet. 1998. Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor. J. Neurochem., 70: 2406-2415.
44. Miller, P. J., and L. Zaborszky. 1997. 3-Nitropriopionic acid neurotoxicity: visualization by silver staining and implications for use as an animal model of Huntington's disease. Exp. Neurol. 146: 212-229.
45. Muthane, U., K. A. Ramsay, H. Jiang, V. Jackson-Lewis, D. Donaldson, S. Fernanado, M. Ferreira, and S. Przedborski. 1994. Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 mice. Exp. Neurol. 126: 195-204.
46. Nachlas, M. M., K. C. Tsou, E. Souza, C. S. Cheng, and A. M. Seligman. 1957. Cytochemical demonstration of succinic dehydrogenase by the use of a new p-nitrophenyl substituted ditetrazole. J. Histochem. Cytochem. 5: 420-436.
47. Nishino, H., Y. Shimano, M. Kumazaki, and T. Sakurai. 1995. Chronically administered 3-nitropropionic acid induces striatal lesions attributed to dysfunction of the blood-brain barrier. Neurosci. Lett. 186: 161-164.
48. Nishino, H., M. Kumazaki, A. Fukuda, I. Fujimoto, Y. Shimano, H. Hida, T. Sakurai, S. B. Deshpande, H. Shimizu, S. Morikawa, and T. Inubushi. 1997. Acute 3-nitropropionic acid intoxication induces striatal astrocytic cell death and dysfunction of the blood-brain barrier: Involvement of dopamine toxicity. Neurosci. Res. 27: 343-355.
49. Nitatori, T., N. Sato, S. Waguri, Y. Karasawa, H. Araki, K. Shibanai, E. Kominami, and Y. Uchiyama. 1995. Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J. Neurosci. 15: 1001-1011.
50. Novelli, A., J. A. Reilly, P. G. Lysko, and R. C. Henneberry. 1988. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res. 451: 205-212.
51. Pang, Z., and J. W. Geddes. 1997. Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid: Acute excitotoxic necrosis and delayed apoptosis. J. Neurosci. 17: 3064-3073.
52. Pang, Z., G. H. Umberger, and J. W. Geddes. 1996. Neuronal loss and cytoskeletal disruption following intrahippocampal administration of the metabolic inhibitor malonate: Lack of protection by MK-801. J. Neurochem. 66: 474-484.
53. Paxinos, G., and C. Watson. 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press, London.
54. Portera-Cailliau, C., J. C. Hedreen, D. L. Price, and V. E. Koliatsos. 1995. Evidence for apoptotic cell death in Huntington's disease and excitotoxic animal models. J. Neurosci. 15: 3775-3787.
55. Racine, R. J. 1972. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroenceph. Clin. Neurophysiol. 32: 281-294.
56. Riepe, M., N. Hori, A. C. Ludolph, D. O. Carpenter, P. S. Spencer, and C. N. Allen. 1992. Inhibition of energy metabolism by 3-nitropropionic acid activates ATP-sensitive potassium channels. Brain Res. 586: 61-66.
57. Sato, S., G. T. Gobbel, J. Honkaniemi, Y. Li, T. Kondo, K. Murakami, M. Sato, J.-C. Copin, and P. H. Chan. 1997. Apoptosis in the striatum of rats following intraperitoneal injection of 3-nitropropionic acid. Brain Res. 745: 343-347.
58. Schauwecker, P. E., and O. Steward. 1997. Genetic determinants of susceptibility to excitotoxic cell death: Implications for gene targeting approaches. Proc. Natl. Acad. Sci. USA 94: 4103-4108.
59. Schulz, J. B., D. R. Henshaw, D. Siwek, B. G. Jenkins, R. J. Ferrante, P. B. Cipolloni, N. W. Kowall, B. R. Rosen, and M. F. Beal. 1995. Involvement of free radicals in excitotoxicity in vivo. J. Neurochem. 64: 2239-2247.
60. Schulz, J. B., R. T. Matthews, B. G. Jenkins, R. J. Ferrante, D. Siwek, D. R. Henshaw, P. B. Cipolloni, P. Mecocci, N. W. Kowall, B. R. Rosen, and M. F. Beal. 1995. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J. Neurosci. 15: 8419-8429.
61. Schulz, J. B., P. L. Huang, R. T. Matthews, D. Passov, M. C. Fishman, and M. F. Beal. 1996. Striatal malonate lesions are attenuated in neuronal nitric oxide synthase knockout mice. J. Neurochem. 67: 430-433.
62. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28: 897-916.
63. Streit, W. J., and G. W. Kreutzberg. 1987. Lectin binding by resting and reactive microglia. J. Neurocytol. 16: 249-260.
64. Thomas, L. B., D. J. Gates, E. K. Richfield, T. F. O'Brien, J. B. Schweitzer, and D. A. Steindler. 1995. DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp. Neurol. 133: 265-272.
65. Tobin, A. J. 1990. Genetic disorders: Huntington's disease. In Neurobiology of Disease (A. L. Pearlman and R. C. Collins, Eds.), pp. 257-275. Oxford Univ. Press, New York.
66. Weiss, J. H., D. M. Hartley, J. Y. Koh, and D. W. Choi. 1993. AMPA receptor activation potentiates zinc neurotoxicity. Neuron 10: 43-49.
67. Wexler, N. S., E. A. Rose, and D. E. Housman. 1991. Molecular approaches to hereditary diseases of the nervous system: Huntington's disease as a paradigm. Annu. Rev. Neurosci. 14: 503-529.
68. Wyllie, A. H. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555-556.
69. Zeevalk, G. D., and W. J. Nicklas. 1990. Chemically induced hypoglycemia and anoxia: Relationship to glutamate receptor-mediated toxicity in retina. J. Pharmacol. Exp. Ther. 253: 1285-1292.